Shandong Sinobioway Biomedicine's high P/S ratio and slower ...

Shandong Sinobioway Biomedicine's high P/S ratio and slower growth rate may pose a risk to its share price. Overvaluation and continuation of recent revenue trends could negatively impact the share price.